Senior Director Antibody-Drug Conjugate Drug Linker Process Development
Company: Eli Lilly and Company
Location: Indianapolis
Posted on: July 10, 2025
|
|
Job Description:
At Lilly, we unite caring with discovery to make life better for
people around the world. We are a global healthcare leader
headquartered in Indianapolis, Indiana. Our employees around the
world work to discover and bring life-changing medicines to those
who need them, improve the understanding and management of disease,
and give back to our communities through philanthropy and
volunteerism. We give our best effort to our work, and we put
people first. We’re looking for people who are determined to make
life better for people around the world. Organization Overview:
Bioproduct Research and Development (BRD) is the large-molecule
process development organization within Lilly. BRD is responsible
for material and data generation to support clinical trials and
commercialization of biologic therapeutics such as mAbs and
bioconjugates. Our team will collaborate closely with the
bioconjugation team to accelerate the development of lifesaving new
medicines for our patients. Our antibody-drug conjugate (ADC) team
seeks to perform innovative and cutting-edge research to deliver
complex drug-linkers and bioconjugation methods to support clinical
trials and commercialization. We collaborate with our Synthetic
Molecule Design and Development (SMDD) and biologics development
colleagues to develop this exciting class of new drugs and seek
fundamental learning and platform approaches to their development.
Responsibilities: Our team is tasked with growing the chemistry
infrastructure to conduct the development of highly potent and/or
cytotoxic ADC drug-linkers. We will utilize a combination of
in-house and external development, while building the capabilities
to develop and transfer processes to internal and external
manufacturing partners. A successful applicant should bring a
skillset and knowledge to help grow our team’s capabilities,
research facilities, and infrastructure. Lilly has an expanding and
diverse portfolio of ADCs that require thorough drug-linker process
development and regulatory submission strategies, often with
compressed timelines. Collaborate with other Lilly chemists,
analytical chemists, bioconjugation scientists, biologics
development team, engineers, CMC project management, Lilly
manufacturing partners, and regulatory scientists to develop and
commercialize ADCs. Manage multiple projects and/or material
deliveries simultaneously. Oversee phase appropriate development
activities such as route selection, process definition, and process
characterization. Partner with external development and
manufacturing organizations to quickly deliver on development and
commercialization needs (data and material). Assist with data
collection, assembly, and authorship of regulatory submissions to
support clinical trials and product commercialization. Bridge the
gap between the small and large molecule worlds to understand the
needs of the project and ensure that process development is
thorough and complete. When appropriate, mentor, train and
supervise junior team members in this role. Help drive internal
facilities growth to support highly-potent and/or cytotoxic
material handling. Bring new and useful concepts, methods, and
ideas for how research can be improved to make our group better.
Engage externally through presentations and publications. Identify
and develop chemistry innovations from the outside to complement
existing capabilities and incorporate these innovations across the
portfolio. Help drive and develop the commercial manufacturing
strategy and collaborate with manufacturing partners to deliver
robust chemical processes that are suitable for commercial-scale
manufacturing. Basic Requirements: PhD in synthetic organic
chemistry with 7 years of relevant industrial experience in the
development of small molecules, especially of drug-linkers for ADCs
or other bioconjugates. Additional Skills/Preferences: Working
knowledge of bioconjugation principles and development/purification
methods. Basic understanding of cGMP principles and previous
oversight of cGMP processes. Demonstrated control strategy
development capabilities (e.g. nitrosamine, conjugatable
impurities). Demonstrated registration stability, process
validation, or post-approval process development leadership. Track
record of personnel mentorship and development to grow the next
generation of scientists. Ability to prioritize multiple activities
and thrive in a setting that requires quick movement between
scientific challenges and comfort with ambiguity. An active
scientific curiosity and interest for complementary disciplines
within the pharmaceutical industry. Knowledge of how to safely
manipulate highly-potent and/or cytotoxic compounds in a laboratory
or production environment. Familiarity with preparative scale
chromatographic purification of small molecules. Additional
Information: Potential exposure to chemicals, allergens, and loud
noises. Travel: 0–20% Located in Indianapolis, Indiana, Lilly
Technology Center – North Lilly is dedicated to helping individuals
with disabilities to actively engage in the workforce, ensuring
equal opportunities when vying for positions. If you require
accommodation to submit a resume for a position at Lilly, please
complete the accommodation request form (
https://careers.lilly.com/us/en/workplace-accommodation ) for
further assistance. Please note this is for individuals to request
an accommodation as part of the application process and any other
correspondence will not receive a response. Lilly is proud to be an
EEO Employer and does not discriminate on the basis of age, race,
color, religion, gender identity, sex, gender expression, sexual
orientation, genetic information, ancestry, national origin,
protected veteran status, disability, or any other legally
protected status. Our employee resource groups (ERGs) offer strong
support networks for their members and are open to all employees.
Our current groups include: Africa, Middle East, Central Asia
Network, Black Employees at Lilly, Chinese Culture Network,
Japanese International Leadership Network (JILN), Lilly India
Network, Organization of Latinx at Lilly (OLA), PRIDE (LGBTQ
Allies), Veterans Leadership Network (VLN), Women’s Initiative for
Leading at Lilly (WILL), enAble (for people with disabilities).
Learn more about all of our groups. Actual compensation will depend
on a candidate’s education, experience, skills, and geographic
location. The anticipated wage for this position is $144,000 -
$250,800 Full-time equivalent employees also will be eligible for a
company bonus (depending, in part, on company and individual
performance). In addition, Lilly offers a comprehensive benefit
program to eligible employees, including eligibility to participate
in a company-sponsored 401(k); pension; vacation benefits;
eligibility for medical, dental, vision and prescription drug
benefits; flexible benefits (e.g., healthcare and/or dependent day
care flexible spending accounts); life insurance and death
benefits; certain time off and leave of absence benefits; and
well-being benefits (e.g., employee assistance program, fitness
benefits, and employee clubs and activities).Lilly reserves the
right to amend, modify, or terminate its compensation and benefit
programs in its sole discretion and Lilly’s compensation practices
and guidelines will apply regarding the details of any promotion or
transfer of Lilly employees. WeAreLilly
Keywords: Eli Lilly and Company, Fishers , Senior Director Antibody-Drug Conjugate Drug Linker Process Development, Science, Research & Development , Indianapolis, Indiana